Oncogene 1997, 14:2729–2733.PubMedCrossRef 18. Mueller-Pillasch F, Pohl B, Wilda M, Lacher U, Beil M, Wallrapp C, Hameister H, Knochel W, Adler G, Gress TM: Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999, 88:95–99.PubMedCrossRef 19. Kobel M, Xu HD, Bourne PA, Spaulding BO, Shih IM, Mao TL, Soslow RA, Ewanowich CA, Kalloger
SE, Mehl E, Lee CH, Huntsman D, Gilks CB: IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian CB-839 molecular weight carcinoma of clear cell subtype. Mod Pathol 2009, 22:469–475.PubMedCrossRef 20. Yaniv K, Yisraeli JK: The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. AG-120 mw Gene 2002, 287:49–54.PubMedCrossRef 21. Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z: The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol 2008, 32:304–315.PubMedCrossRef 22. Lu D, Yang XF, Jiang NY, Woda BA, Liu Q, Dresser K, Mercurio AM, Rock KL, Jiang Z: IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer. Am J Surg Pathol 2011, 35:1638–1645.PubMedCrossRef 23. Li CZ, Rock KL, Woda BA, Jiang Z, Fraire
AE, Dresser K: IMP3 is a novel biomarker for Pexidartinib in vitro adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 2007, 20:242–247.PubMedCrossRef 24. Findeis-Hosey JJ, Xu H: Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer. Biotech Histochem 2012, 87:24–29.PubMedCrossRef Erlotinib 25. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber
JE, Cramer DW, Crum CP: The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006, 30:230–236.PubMedCrossRef 26. Jarboe E, Folkins A, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee YH, Crum CP: Serous carcinogenesis in the fallopian tube: A descriptive classification. Int J Gynecol Pathol 2008, 27:1–9.PubMedCrossRef 27. Jiang Z, Chu PGG, Woda BA, Rock KL, Liu Q, Hsieh CC, Li CZ, Chen WG, Duan HO, McDougal S, Wu CL: Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol 2006, 7:556–564.PubMedCrossRef 28. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K: KOC (K homology domain containing protein overexpressed in cancer) – A novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005, 29:188–195.PubMedCrossRef 29.